chrisvoncsefalvay/vaers-outcomes huggingface dataset:
24hr p/vax devel temp of 103 x 2-3 days;also had sx muscle achiness, general fatigue, runny nose;had low grade fever x7 days;devel productive cough dx w/pneumonia;PMD recommended report this as adverse reaction to flu vax;
Red bumpy rash that was warm to the touch at the injection site; Red bumpy rash that was warm to the touch at the injection site; Red bumpy rash that was warm to the touch at the injection site; Headache; Vaccination Site Rash; Hives; This spontaneous case was reported by a consumer and describes the occurrence of URTICARIA (Hives), VACCINATION SITE WARMTH (Red bumpy rash that was warm to the touch at the injection site), VACCINATION SITE PRURITUS (Red bumpy rash that was warm to the touch at the injection site), VACCINATION SITE ERYTHEMA (Red bumpy rash that was warm to the touch at the injection site) and HEADACHE (Headache) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 029L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Penicillin allergy (30 years ago).    On 22-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 31-Jan-2021, the patient experienced URTICARIA (Hives). On an unknown date, the patient experienced VACCINATION SITE WARMTH (Red bumpy rash that was warm to the touch at the injection site), VACCINATION SITE PRURITUS (Red bumpy rash that was warm to the touch at the injection site), VACCINATION SITE ERYTHEMA (Red bumpy rash that was warm to the touch at the injection site), HEADACHE (Headache) and VACCINATION SITE RASH (Vaccination Site Rash). At the time of the report, URTICARIA (Hives), VACCINATION SITE WARMTH (Red bumpy rash that was warm to the touch at the injection site), VACCINATION SITE PRURITUS (Red bumpy rash that was warm to the touch at the injection site), VACCINATION SITE ERYTHEMA (Red bumpy rash that was warm to the touch at the injection site), HEADACHE (Headache) and VACCINATION SITE RASH (Vaccination Site Rash) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Case comment: Based on the current available information and temporal association between the use of the product and the start date of these events, a causal relationship cannot be excluded.   Most recent FOLLOW-UP information incorporated above includes: On 08-Apr-2021: Follow up received captured reporter email address.; Reporter's Comments: Based on the current available information and temporal association between the use of the product and the start date of these events, a causal relationship cannot be excluded.
Vomiting and H/A at pain level of 8.  Lasted until 9/30.  Treated with Midrin and APAP.
Shot was administered in the left arm.  2 weeks after 2nd dose vaccination, I experienced bloody discharge from left breast.  October 2021, a diagnostic mammogram, ultrasound, and a MRI ruled out cancer.  Breast tissue is normal.
Patient came to clinic on 03-07-12 for private pay Hep B and flu vaccine. Client was given adult Hep B which is for age 20 years and up when the client is only age 19 years, 5 months. No adverse reactions.
Skin Legions began forming in arm pits and then spread on upper torso.; Skin Legions began forming in arm pits and then spread on upper torso.; The legions are irritating, flat red inflamed about the size of a penny all over front torso.; The legions are irritating, flat red inflamed about the size of a penny all over front torso.; Feeling of something crawling under skin is now sharp stabbing pain on legion areas- like needles poking my body.; Slight exhaustion; This is a spontaneous report received from a contactable consumer (patient). A 50 year-old female non pregnant patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Batch/Lot number: Unknown (Reason: Unable to locate or read the details) via an unspecified route of administration, administered in Arm Left on an unspecified date (Age at Vaccination: 49 year-old) as DOSE 2, SINGLE for COVID-19 immunisation. The patient was not pregnant at the time of vaccination. The patient medical history was not reported. Concomitant medications included tetanus vaccine (TETANUS VACCINE) taken in Arm Right for an unspecified indication on 03Jan2021 (vaccines within 4 weeks prior to the COVID vaccine), other medications the patient received within 2 weeks of vaccination included sertraline hydrochloride (ZOLOFT), alprazolam (XANAX). The patient received other vaccines within 4 weeks prior to the COVID vaccine and Location of injection information was available for it. Prior to vaccination, was the patient was not diagnosed with COVID-19 and since the vaccination, the patient has not been tested for COVID-19. The patient previously took compazine [prochlorperazine maleate] and experienced Allergies, took bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Batch/Lot number: Unknown) via an unspecified route of administration, administered in Arm Left on 20Jan2021 at 11:00 AM (Age at Vaccination: 49 year-old) as DOSE 1, SINGLE for COVID-19 immunisation and experienced Heat radiating through body, Skin lesion under left breast, feel sensations under my skin, like insects crawling under skin and Slight exhaustion. After the 2nd dose. Patient stated that her Skin Legions began forming in arm pits and then spread on upper torso. The legions were irritating, flat red inflamed about the size of a penny all over front torso. Had Feeling of something crawling under skin was now sharp stabbing pain on legion areas- like needles poking her body. She had no fever or other side effects, she felt slight exhaustion a few days after initially receiving vaccine. The adverse events resulted in doctor or other healthcare professional office/clinic visit. Treatment received for the adverse events was with Oral steroid and topical prescription lotions. Outcome of events at the time of last observation was not recovered.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
4 vesicles at injection site, no fever, no systemic symptoms and no other lesions.
Bumps (rash) at the injection site measuring 2 inches wide and 3 inches high; Sore at the injection site; This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 15-Jan-2021 and was forwarded to Moderna on 15-Jan-2021.    This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (Sore at the injection site) and VACCINATION SITE RASH (Bumps (rash) at the injection site measuring 2 inches wide and 3 inches high) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 027L20A) for COVID-19 vaccination.     The patient's past medical history included No adverse event (No reported medical history).    On 07-Jan-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. In January 2021, the patient experienced VACCINATION SITE PAIN (Sore at the injection site). On an unknown date, the patient experienced VACCINATION SITE RASH (Bumps (rash) at the injection site measuring 2 inches wide and 3 inches high). At the time of the report, VACCINATION SITE PAIN (Sore at the injection site) and VACCINATION SITE RASH (Bumps (rash) at the injection site measuring 2 inches wide and 3 inches high) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant product use was not provided by the reporter. Treatment medication included Cortisone.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded
Left arm pain to fingers, fatigue, myalgias, chills, sweats and diarrhea, abdominal pain, swelling and redness at site of injection. Feverx2d.
Hives on face and trunk (6 hours) Low grade temp, achy (two days)
This initial spontaneous report was received from a registered medical assistant referring to an unspecified number of patients of unknown ages and genders. There was no pertinent medical history, concomitant medication, concurrent conditions or drug allergies/drug reactions described. On unspecified dates, the patients were vaccinated with improperly stored doses of VAQTA injection (lot # L039659 with expiration date 15-MAR-2017; dose and route were not provided). No adverse effect was reported. It was unknown if the patients sought medical attention. Product quality complaint (PQC) was not involved. This is one of several reports received from the same reporter. Additional information has been requested.
Information has been received from a medical assistant concerning 5 pts who were vaccinated with pneumococcal vaccine 23 polyvalent. The pts developed cellulitis and were treated in the local ER. No other information was available at the time of this report. Upon internal review cellulitis was determined to be an "Other Important Medical Event". Additional information has been requested. In follow up the MA reported that she has no additional information regarding these cases. She stated that shewas the initial person who reported these events but a nurse in the practice finished the reporting. She further stated taht the medical practice was closing at the end of January 2002 and the nurse would only be in the office one day next week. Upon internal review, cellulitis was determined to be an other important medical event. No additional information is available.
Redness and swelling around injection site and spreading to underarm. Started on cephalexin 500 mg PO TID for 10 days on 12/19/13.
When I received the shot I had no reaction at all not even a sore arm.  Within a few days I started getting terrible pains in the calves of my legs.  Then a few days later  I got a purple line on my right calf that was painful.  The next day I had 3 big yellow spots on the same leg. They went away in 2 days which I thought was odd.  Next day I got a very large bruise at the vaccine location.    After that I started with pains in all of my joints.  Ever since then I have been having pains in all my joints.  The pain level is not going away and has been getting worse
No additional AEs or PQC reported; patient received PROQUAD and VARlVAX vaccines at same time; This spontaneous report was received from an office manager referring to a patient of unknown age and gender. Information about medical history, concurrent conditions and concomitant therapies was not provided.    On 14-SEP-2021, the patient was vaccinated with measles, mumps, rubella and varicella (oka-merck) virus vaccine live (rHA (recombinant Human albumin)) (PROQUAD) (lot # T034612, expiration date 10-APR-2022, 0.5 milliliter, subcutaneous) and varicella virus vaccine live (oka/merck)(VARIVAX) (lot # T040418, expiration date 01-DEC-2022, 0.5 milliliter, subcutaneous) at same time for prophylaxis (overdose). No adverse event was reported.
Info has been received from a health professional concerning a 2 year old male who on 8/14/03 was vaccinated with a dose of varicella virus vaccine live. Subsequently, the pt developed herpes zoster with no complications or hospitalizations. Unspecified medical attention was sought. There was no product quality complaint. Additional info has been requested.
This spontaneous report as received from a registered nurse refers to an unspecified number of patients of unknown age and genders. The reporter stated that, on an unspecified date, an unknown number of doses of LIQUID PEDVAXHIB, (dose, lot#, expiration dates not provided) that were stored at 48 degrees F for 20 minutes, then exposed to 47 degrees for 9 minutes have been administered. No adverse effects were reported.   Follow up information had been received on 22-JUL-2014 from a receptionist. The reporter stated that there were two different lot numbers of LIQUID PEDVAXHIB that were included in the temperature excursion: Lot # J016188, expiration date: 02-OCT-2016 and lot # J015437, expiration date: 09-OCT-2016. The receptionist did not have any additional information to share.  Follow-up information has been received from the registered nurse who provided patients details. This report refers to a 4 weeks old patient of unknown gender. On 10-JUN-2014 the patient was vaccinated with a dose of LIQUID PEDVAXHIB (dose and route were not reported), lot#J016188, expiration date: 02-OCT-2016 that was improperly stored. No adverse effects were reported.  This is one of several reports received from the same reporter. Additional information is not expected.
I am 56 so I went to pharmacy for the Shingrix as recommended. In April after the IM injection I developed a severe headache within 12 hours of the med. The headache was unrelieved for approximately 24 hours despite Advil and hydration it was primarily occipital with sensitivity to light. I do not have a history of migraines and I rarely get a headache unless experiencing the flu. I very much did not want the second vaccine but was told it would not be effective if I did follow though. My sister is immuno-compromised so I did not want the risk of being a carrier of this. I proceeded to get the second vaccine again at pharmacy at 8pm last night. I took an Advil in the car immediately after. Within an hour my shoulder began aching to the point of having difficulty moving it without pain. By this am 12 hours after I severe body aches and chills. The only way I could relieve the rigors from the chills was by submerging myself in a hot bath. Then again an occipital headache and mild light sensitivity. It is now 340 pm and I have body aches, light sensitivity occipital ache and flu like symptoms despite Advil.
25mins post vaccination pt reported dizziness and anxiety. Vitals: 147/80, 71, 20, 100% -- > 155/79, 57 Pt stable and released from the vaccination site.  Recommended f/u w/ PCP if sx continue tomorrow
13JUL95 devel rt knee pain on 14JUL95 the pain was also in lt knee, hands, feet wrists elbows;pain left pt immobile;MD put pt on Naprosyn; dx acute arthritis;
No adverse reaction; patient inadvertently received 1st dose from an unauthorized age group (6-11) vial.; This spontaneous case was reported by a nurse and describes the occurrence of INCORRECT DOSE ADMINISTERED (patient inadvertently received 1st dose from an unauthorized age group (6-11) vial.) and NO ADVERSE EVENT (No adverse reaction) in a 4-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 064A22A) for COVID-19 vaccination.     The patient had no known allergies.     On 11-Aug-2022, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) .25 dosage form. On 11-Aug-2022, the patient experienced INCORRECT DOSE ADMINISTERED (patient inadvertently received 1st dose from an unauthorized age group (6-11) vial.). On an unknown date, the patient experienced NO ADVERSE EVENT (No adverse reaction). At the time of the report, INCORRECT DOSE ADMINISTERED (patient inadvertently received 1st dose from an unauthorized age group (6-11) vial.) and NO ADVERSE EVENT (No adverse reaction) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter considered NO ADVERSE EVENT (No adverse reaction) to be not related. No further causality assessment was provided for INCORRECT DOSE ADMINISTERED (patient inadvertently received 1st dose from an unauthorized age group (6-11) vial.).    No concomitant medications were provided by the reporter.  Patient's height was reported as 44 7/8 inches.   No treatment medications were provided by the reporter.
A single blister (less than 1cm in diameter) appeared at back of roof of mouth near rear-most molar on left side. Gums inflamed and bleeding around tooth number 12 when brushing teeth in the morning. Blister broke within 3 hours of being noticed, leaving a slightly tender spot on roof of mouth. Around 11pm on 13 March, right outer ear felt warm, tender to the touch, and inflamed. (For decades, I have been regularly experiencing headaches once or twice a month and this ear often becomes tender at the same time of the headaches. I did not have a headache during this occurrence of outer ear pain.)
Pt. received vaccine on 4-9-13 then presented with rash 4-13-13, then ER 4-20-13 dx with fifth disease. Pt. eval. by PCP on 4-22-13 dx with varicella.
vaccine almost killed my 2 yr old / I nearly lost my 2 yr old due to vaccine injury; Initial information and additional information received on 14-Oct-2020 regarding an unsolicited valid non-serious case from a social media via consumer or non-healthcare professional.  This case involves a 2-year-old patient (gender not reported) for whom parent reported that "nearly lost the patient due to vaccine injury/ vaccine almost killed the patient" (vaccination complication), while he/she received INFLUENZA VACCINE [Flue shot].  Medical history, medical treatment, vaccination, concomitant medication and family history were not provided.   On an unknown date, the patient received a dose of suspect INFLUENZA VACCINE (produced by unknown manufacturer) [lot number and expiry date not reported] via an unknown route at an unknown administration site for prophylactic vaccination.  On an unknown date, the patient's parent nearly lost the patient due to vaccine injury/ vaccine almost killed the patient(vaccination complication) (unknown latency) following the administration of INFLUENZA VACCINE.   Details of laboratory data not reported.   It was not reported if the patient received any corrective treatment.  The event outcome was unknown at the time of reporting.   There will be no information available on the batch number for this case.; Sender's Comments: This case involves a female patient (age unspecified) who experienced vaccination complication with INFLUENZA VACCINE [flu shot]. The time to onset was unknown. Further information regarding concurrent condition during vaccination, previous vaccination and tolerance, laboratory investigations and other alternative etiologies for the reported event are needed to fully assess this case. Based upon the reported information, the role of the suspect vaccines cannot be assessed.
Ringing in left ear.   I'm not worried about it.  I just thought someone would want to know.
bruise on my left upper thigh; fungal rash; itch; hives; This is a spontaneous report from a contactable consumer (Patient). A 36-years-old male patient received bnt162b2 (PFIZER-BOTECH COVID-19 VACCINE, Solution for injection, Lot Number: EW0172), via an unspecified route of administration, administered in Arm Left on 21Apr2021 09:15 (age at vaccination: 36-years-old) as dose2, single for covid-19 immunization. Medical history included asthma. Concomitant medication received within 2 weeks of vaccination included budesonide, formoterol fumarate (SYMBICORT), loratadine, pseudoephedrine sulfate (CLARITIN D 12 HOUR) all taken for an unspecified indication, start and stop date were not reported. Patient did not receive any other vaccine within 4 weeks prior to the Covid vaccine. Prior to vaccination patient was not diagnosed with Covid-19. Historical vaccine included first dose of bnt162b2 (PFIZER-BOTECH COVID-19 VACCINE, Solution for injection, Lot Number: ER8732), via an unspecified route of administration, administered in Arm Left on 24Mar2021 01:15 PM for covid-19 immunization (age at vaccination: 36-years-old). It was reported that a day after second dose, on 22Apr2021 17:30 patient noticed a quarter size bruise on his left upper thigh. A few days later that bruise started to itch. About a week and a half there was bright red hive and bruising that spread all over his upper leg that had an extreme itch then same hives and bruising appeared on his right leg in same general area. His general physician doctor thought it was a fungal rash his treatment did not work then went to dermatologist there treatment of a steroid cream and antihistimine did not work then went to Emergency room where he was prescribed an oral steriod which has helped the itch but the rash/hives have still not gone away. We are going on 3.5 weeks and waiting on a biopsy. Patent was not tested for covid-19 Since the vaccination. Patient was not hospitalized for the event. Adverse events resulted in Doctor or other healthcare professional office/clinic visit and Emergency room/department or urgent care. Therapeutic measures were taken as a result of events with Steroid cream, Antihistamines, Oral steroid. Outcome for the events was not resolved at the time of this report.   Follow-up (19Jul2021 and 23Jul2021): Follow-up attempts completed. No further information expected.
Severe watery diarrhea for beginning day 2 after vaccine and continues into day 4.
Right sided throat tightness. Seen by onsite EMTs, Pt. c/o cx tightness, mild itchiness in throat. V/S: Lung sound clear=bilateral. vital signs monitored WNL. 12-Lead ECG-NSR; 0 ectopy; 0 elevation, decrease. Orthostatic BP WNL, 0 change. Pt. stated that symptoms relieved after extended observation time. Pt. felt WNL at time of departure.  Final V/S: B.P. 126/80; Pulse=70; SPO2=97% RA. Discharged home at 11:30 A.M.
This spontaneous report as received from a pharmacist refers to a 71 year old female patient with end stage renal disease. The patient's drug reactions or allergies were unknown by the reporter. On 17-JUN-2016 (also reported as on 17-JUN-2017), the patient was vaccinated with a 0.65 ml dose of ZOSTAVAX (lot # M005727, once, route of administration and expiration date were not reported) for prevention of shingles. The patient's  concomitant medications were not provided. On approximately 19-JUN-2016 (reported as two to three days, after receiving the ZOSTAVAX, the patient experienced pain around the left shoulder blade, radiating to the back, unspecified swelling, nausea and diarrhea. No treatment was given for the adverse events. The patient contacted the pharmacist on 27-JUN-2016 to inform the pharmacist of adverse effects and reported symptoms were not improving, and had worsened. Causality assessment between the adverse events and the ZOSTAVAX was not provided. Additional information has been requested.
Minutes after getting the vaccine patient said she was feeling lightheaded. We went to check on her and she fainted. EMS was called. Patient was unconscious for roughly 15 seconds. We checked pulse and positioned on the floor. Once responsive patient said she was feeling okay. She said she faints when she gets anxious (this was not disclosed before vaccine was given). She spoke with EMS who determined she did not need immediate care. She waited another roughly 30 minutes and was able to leave the pharmacy.
PULMONARY EMBOLISM, UNSPECIFIED. 4/15/2021 HYPOXIA  ACUTE RESPIRATORY FAILURE 4/15/2021 HYPOXIA  ACUTE HYPERCAPNIC RESPIRATORY FAILURE 4/15/2021 HYPOXIA  PULMONARY EMBOLISM, UNSPECIFIED. 4/15/2021 ACUTE HYPOXEMIC RESPIRATORY FAILURE  ACUTE RESPIRATORY FAILURE 4/15/2021 ACUTE HYPOXEMIC RESPIRATORY FAILURE  ACUTE HYPERCAPNIC RESPIRATORY FAILURE 4/15/2021 ACUTE HYPOXEMIC RESPIRATORY FAILURE
Patient came into the pharmacy on April 16th in the morning about 10:45AM for her second Moderna booster. We have her Moderna 0.25mL on her left arm. She sat down for 15 mins and left home. No adverse side effects at the pharmacy. However, her family member reported to us on April 19th at around 13:55pm that patient went to the hospital on April 17th at 6AM in the morning. Per medical report, patient was experiencing chills, fever, elevated heart enzymes due to a mild case of myocarditis. Patient was released from the hospital after 23hrs and is home and okay.
Shortness of breath, heavy weight on my chest,  feeling weak, needed to sit or lay down.